Aldo Ferrari

ETH Zurich

Papers

1

Total Citations

2

H-Index

1

About

Aldo Ferrari is a pioneering biomedical engineer whose work sits at the intersection of mechanobiology, cardiovascular research, and advanced materials. As a key figure at the Swiss Federal Institute of Technology (ETH Zurich), Ferrari helped launch the groundbreaking ETHeart program, an interdisciplinary initiative that fuses engineering, biology, and clinical medicine to tackle some of the most pressing cardiovascular challenges. His major contributions include developing innovative solutions for myocardial infarction, designing next-generation heart valve replacements, and creating movement-based rehabilitation therapies that leverage biomechanical principles. Though his most cited work—the ETHeart story (2022, 2 citations)—is still emerging, its vision reflects Ferrari’s broader impact: bridging fundamental science with translational applications. His research has been instrumental in shaping how mechanobiology informs cardiovascular device design, and his leadership in fostering cross-disciplinary collaboration has inspired a new generation of bioengineers. With a career marked by a commitment to solving real-world clinical problems, Ferrari continues to push the boundaries of what is possible in regenerative medicine and cardiovascular engineering, making him a vital voice in the future of heart health.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Building an interdisciplinary program of cardiovascular research at the Swiss Federal Institute of Technology– the ETHeart story
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: ETH Zurich

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago